Диссертация (1140276), страница 24
Текст из файла (страница 24)
Bai, X. Zhu, J. Chao [etal.] // PLoS One. – 2015. – Vol.10, №4. – P. e0124362.145103.Bailey, D.M. Erythropoien depletes iron strokes: an oxidant neuroprotection forischemic stroke? / D.M. Bailey, P. Robach, J.J. Thomsen [et al.] // Stroke. – 2006. –Vol.37. – P. 2453.104.Bauer, С.
Erythropoietin – from gene structure to therapeutic applications / С.Bauer // J. Perinat. Med. – 1995. – Vol. 23, №1-2. – Р.77-81.105.Becker, K.J. Intraarterial thrombolysis in vertebrobasilar occlusion / K.J.Becker, L.H. Monsein, J. Ulatowski [et al.] // AJNR Am J Neuroradiol. – 1996. –Vol.17, №2. – P. 255-262.106.Becker, K.J. Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab(R6.5) in acute stroke / K.J. Becker // Curr Med Res Opin.
– 2002. – Vol.18. – P. s18s22.107.Beckman, B.S. The action of erythropoietin is mediated by lipoxygenasemetabolits in murine fetal liver cells / B.S. Beckman, M. Mason, L. Nystuen [et al.] //BBRC. – 1987. – Vol.147. – P. 392-397.108.Bennett, M.R.Neuronal cell death in the mammalian nervous system: thecalmortin hypothesis / M.R.Bennett, K.R. Huxlin// Gen Pharmacol.
– 1996. – Vol.27,№3. – P. 407-419.109.Beretta, S. Cerebral collateral flow defines topography and evolution ofmolecular penumbra in experimental ischemic stroke / S. Beretta, E. Cuccione, A.Versace [et al.] // Neurobiol Dis. – 2015. – Vol.74.
– P.305-313.110.Bernaudin, M. Neurons and astrocytes express EPO mRNA: oxygen– sensingmechanisms that involve the redox-state of the brain / M. Bernaudin, A. Bellail, H.H.Marti [et al.] // Glia. – 2000. – Vol. 30, №3. – Р.271-278.111.Beru, N. Expression of the erythropoietin gene / N. Beru, J. McDonald, C.Lacombe [et al.] // Mol. Cell. Biol. – 1986. – Vol.6. – P. 2571-2575.112.Biggar, P. Treatment of renal anemia: Erythropoiesis stimulating agents andbeyond / P.Biggar, G.H. Kim // Kidney Res Clin Pract. – 2017. – Vol.36, №3. – P. 209223.146113.Blixt, J.Erythropoietin Attenuates the Brain Edema Response afterExperimental Traumatic Brain Injury / J.Blixt, E.Gunnarson, M.
Wanecek //JNeurotrauma. – 2018. – Vol.35, №4. – P. 671-680.114.Bogaert, L. Neurochemical changes and laser Doppler flowmetry in theendothelin-1 rat model for focal cerebral ischemia / L. Bogaert, D. Scheller, J. Moonen[et al.] // Brain Res. – 2000. – Vol.887, №2. – P. 266-275.115.Boyraz, I. Comparison of high-intensity laser therapy and ultrasound treatmentin the patients with lumbar discopathy / I.
Boyraz, A. Yildiz, B. Koc [et al.] // BiomedRes Int. – 2015. – Vol.2015. – P. 304328.116.Bramlett, H.M. Pathophysiology of cerebral ischemia and brain trauma:similarities and differences / H.M. Bramlett, W.D. Dietrich // J Cereb Blood FlowMetab. – 2004. – Vol.24, №2.
– P. 133-150.117.Brines, M.L. Erythropoietin crosses the blood-brain barrier to protect againstexperimental brain injury / M.L. Brines, P. Ghezzi, S. Keenan [et al.] // Proc Natl AcadSci USA. – 2000. – Vol.97. – P. 10526-10531.118.Brouns, R.The complexity of neurobiological processes in acute ischemic stroke/ R.Brouns, P.P.De Deyn // Clin Neurol Neurosurg. – 2009. – Vol.111, №6. – P. 483495.119.Buemi, M. Erythropoietin and the brain: from neurodevelopment toneuroprotection / M. Buemi, E.
Cavallaro, F. Floccari [et al.] // Clin Science. – 2002. –Vol. 103, №3. – Р. 275-282.120.Byts, N.Essential role for Stat5 in the neurotrophic but not in theneuroprotective effect of erythropoietin / N. Byts, A. Samoylenko, T. Fasshauer [et al.]// Cell Death Differ. – 2008.
– Vol.15. – P. 783-792.121.Cao, F. Delayed neuronal cell death in brainstem after transient brainstemischemia in gerbils / F. Cao, R. Hata, P.Zhu [et al.] // BMC Neurosci. – 2010. – Vol.11.– P. 115.122.Carone, D. Pravastatin acute neuroprotective effects depend on blood brainbarrier integrity in experimental cerebral ischemia / D. Carone, L. Librizzi, A.Cattalini[et al.]// Brain Res.
– 2015. – Vol.1615. – P. 31-41.147123.CAST: randomised placebo-controlled trial of early aspirin use in 20,000patients with acute ischaemic stroke // Lancet. – 1997. – Vol. 349, №9066. – P. 16411649.124.Celik, M. Erythropoietin prevents motor neuron apoptosis and neurologicdisability in experimental spinal cord ischemic injury / M. Celik, N. Gokmen, S.Erbayraktar [et al.] // Proc Natl Acad Sci USA.
– 2002. – Vol.99. – P. 2258-2263.125.Chandel, N.S. Mitochondrial reactive oxygen species trigger hypoxiainducedtranscription / N.S. Chandel, E. Maltepe, E. Goldwasser [et al.] // Proc. Natl. Acad. Sci.U.S.A. – 1998. – Vol.95. – P.11715-11720.126.Chang, Y.L. Associa on between ischemic stroke and iron-de ciency anemia: apopula on based study / Y.L. Chang, S.H. Hung, W. Ling [et al.] // PLoS ONE. – 2013.– Vol.8. – P. 82952.127.Chen, S.T.A model of focal ischemic stroke in the rat: reproducible extensivecortical infarction / S.T.Chen, C.Y.Hsu, E.L.Hogan [et al.] // Stroke. – 1986. – Vol.17,№4. – P. 738-743.128.Chikuma, M.
Tissue– specifc regulation of erythropoietin production in themurine kidney, brain and uterus / M. Chikuma, S. Masuda, T. Kobayashi [et al.] // Am.J. Physiol. Endocrinol.Metab. – 2000. – Vol.279. – P. 1242-1248.129.Chung, H. The nuts and bolts of low-level laser (light) therapy / H. Chung, T.Dai, S.K. Sharma [et al.] // Ann Biomed Eng. – 2012. – Vol.
40, №2. – P. 516-533.130.Citow, J.S. Comprehensive Neurosurgery Board Review / J.S. Citow, R. LochMacdonald, D. Refai. – New York; Stuttgart: Thieme, 2009. – 576 p.131.D’Andrea, A.D. Erythropoietin receptor. Subunit structure and activation / A.D.D’Andrea, L.I. Zon // J. Clin. Invest. – 1990. – Vol.
86, №3. – P. 681-687.132.DeDeyn, P.P. Treatment of acute ischemic Stroke with piracetam. Members ofthe Piracetamin Acute Stroke Study (PASS) Group / P.P. DeDeyn, J.D. Reuck, W.Deberdt [et al.] // Stroke. – 1997. – Vol. 28. – P. 2347-2352.133.Del Zoppo G.J. Ischaemic damage of brain microvessels: inherent risks forthrombolytic treatment in stroke / G.J. Del Zoppo, R. von Kummer, G.F. Hamann // JNeurol Neurosurg Psychiatry. – 1998. – Vol.65, №1. – P.1-9.148134.Del Zoppo, G.J. Expansion of the Time Window for Treatment of AcuteIschemic Stroke With Intravenous Tissue Plasminogen Activator:A Science AdvisoryFrom the American Heart Association/American Stroke Association/ G.J. Del Zoppo,J.L.
Saver, E.C. Jauch [et al.] // Stroke. – 2009. – Vol.40. – P. 2945-2948.135.Del Zoppo, G.J. The neurovascular unit in the setting of stroke / G.J. Del Zoppo// J. Intern. Med. – 2010. – Vol.267, №2. – P. 156-171.136.Doggrell, S.A. A neuroprotective derivative of erythropoietin that is noterythropoietic / S.A. Doggrell // Expert. Opin. Investing. Drugs. – 2004. – Vol. 13,№11. – P.
1517-1519.137.Donnan, G.A. Stroke / G.A. Donnan, M. Fisher, M. Macleod [etal.] // Lancet. –2008. – Vol. 71, №9624. – P. 1612-1623.138.Dundar, U. Effectiveness of high-intensity laser therapy and splinting in lateralepicondylitis; a prospective, randomized, controlled study / U. Dundar, U. Turkmen, H.Toktas [et al.] // Lasers Med Sci. – 2015. – Vol.30, №3.
– P. 1097-1107.139.Dzietko, M. Delayed VEGF treatment enhances angiogenesis and recoveryafter neonatal focal rodent stroke / M.Dzietko, N.Derugin, M.F. Wendland [et al.] //Transl Stroke Res. – 2013. – Vol.4, №2. – P. 189-200.140.Ebid, A.A. Long-term effect of pulsed high-intensity laser therapy in thetreatment of post-mastectomy pain syndrome: a double blind, placebo-control,randomized study / A.A. Ebid, A.M.
El-Sodany // Lasers Med Sci. – 2015. – Vol.30,№6. – P. 1747-1755.141.Eckert, B. Endovascular therapy of acute vertebrobasilar occlusion: earlytreatment onset as the most important factor / B. Eckert, T. Kucinski, G. Pfeiffer [et al.]// Cerebrovasc Dis. – 2002. – Vol.14, №1. – P. 42-50.142.Erman, A. Effects of bivalent cations on prostaglandin biosynthesis andphospholipase A2 activation in rabbit kidney medulla slices / A. Erman, R.
Amiran //Biochem. J. – 1979. – Vol.182. – P. 821-825.143.Erythropoietin and the Nervous System / ed. A. Höke. – Berlin: Springer, 2006.– 224 p.149144.Fantacci, M.Carbamylated erythropoietin ameliorates the metabolic stressinduced in vivo by severe chronic hypoxia / M. Fantacci, P. Bianciardi, A. Caretti//ProcNatlAcadSciUSA. – 2006. – Vol.103, №46. – P.
17531-17536.145.Faure, S. Synergistic protective effects of erythropoietin and olmesartan onischemic stroke survival and post– stroke memory dysfunctions in the gerbil / S. Faure,N. Oudart, J. Javellaud // J Hypertens. – 2006. – Vol.24, №11. – P.2255-2261.146.Fenjves, E.S. Human, nonhuman primate, and rat pancreatic islets expresserythropoietin receptors / E.S. Fenjves, M.S. Ochoa, O. Cabrera [et al.]//Transplantation.
– 2003. – Vol. 75. – P. 1356-1360.147.Fisher, M. Prophylactic neuroprotection for cerebral ischemia / M. Fisher, S.Jonas, R.L. Sacco [et al.] // Stroke. – 1994. – Vol.25, №5. – P. 1075-1080.148.Forder, J.P.Postsynaptic mechanisms of excitotoxicity: Involvement ofpostsynaptic density proteins, radicals, and oxidant molecules / J.P. Forder,M.Tymianski // Neuroscience. – 2009. – Vol.158, №1.
– P. 293-300.149.Furlan, A.J. Dose Escalation of Desmoteplase for Acute Ischemic Stroke(DEDAS): Evidence of Safety and Efficacy 3 to 9 Hours After Stroke Onset / A.J.Furlan, D. Eyding, G.W. Albers [et al.] // Stroke. – 2006. – Vol.37. – P. 1227-1231.150.Garcia, J.H. Early reperfusion as a rationale form of therapy in ischemic stroke /J.H. Garcia // Rev. Neurol. – 1995. – Vol. 23, №123.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
